NEW Australian research published in the MJA has revealed high risk rural patients are not receiving anticoagulant therapy when most should be taking non-vitamin K oral anticoagulant (NOAC) therapy, which has been shown to be safer than warfarin.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 16 Jan 18
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jan 18
